🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07035262
Active, not recruiting Observational

Impact of Pre- and Post-operative Serum Metabolome Dynamics in Colorectal Resection Outcomes

NCT07035262 · tracked via the Priya Life Science China tracker
Sponsor
Dong Peng
Phase
Observational
Started
2023-01-01
Last updated
2025-06-25

Condition(s) studied

Colo-rectal Cancer

Investigational drug(s) / intervention(s)

serum metabolites

serum metabolites: serum metabolites before and after colorectal cancer surgery

Study summary

The aim of this study is to systematically analyze the dynamic pattern of preoperative and postoperative serum metabolites in colorectal cancer patients through metabolomics technology, and to screen the key metabolites with statistical differences and explore their correlation with surgical interventions by combining the baseline characteristics of the patients with the perioperative clinical data; to further reveal the impact of surgery on the body's metabolic remodeling pattern, and to explore the potential biomarkers and regulatory pathways, providing a theoretical basis for elucidating the metabolic mechanism. Investigaters will further reveal the impact of surgery on metabolic remodeling, explore potential biomarkers and regulatory pathways, provide theoretical basis for elucidating the metabolic mechanism, and evaluate its clinical translational value (e.g., postoperative monitoring, targeted intervention, etc.), so as to lay the foundation for the subsequent basic research and precise treatment strategies.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Previous consent to participate; * Blood drawn and serum samples extracted and preserved both preoperatively and postoperatively; * Successful detection of metabolomics profiles from serum samples; * Acceptance of a standard radical colorectal cancer procedure; * Complete perioperative data available; * Adults with a pathologic diagnosis of colorectal cancer Exclusion Criteria: * Have or have had a previous history of other malignancies; * Have a history of radiotherapy treatment; * Have a history of inflammatory bowel disease; * Have a familial history of genetic disorders; * Missing baseline data (age, BMI, gender, previous medical history, etc.); * Failed to leave the hospital earlier than medically indicated; * Failed to sign an informed consent form.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The First Affiliated Hospital of Chongqing Medical University Chongqing Chongqing Municipality

More Dong Peng trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07035262 on ClinicalTrials.gov ↗ ← All trials in China